Prognostic and predictive biomarkers for epidermal growth factor receptor-targeted therapy in colorectal cancer: beyond KRAS mutations.

作者: Ana Custodio , Jaime Feliu

DOI: 10.1016/J.CRITREVONC.2012.05.001

关键词:

摘要: … Median time to progression(TTP) was 7.7 and 6.4 months in patients showing increased FISH and CISH EGFR GCN, whereas it was 2.9 and 3.1 months in those with low FISH and …

参考文章(250)
Anindya Dutta, Yong Sun Lee, MicroRNAs: small but potent oncogenes or tumor suppressors. Current opinion in investigational drugs. ,vol. 7, pp. 560- 564 ,(2006)
Wilbur A. Franklin, Jerry Haney, Michio Sugita, Lynne Bemis, Antonio Jimeno, Wells A. Messersmith, KRAS Mutation The Journal of Molecular Diagnostics. ,vol. 12, pp. 43- 50 ,(2010) , 10.2353/JMOLDX.2010.080131
Katsuhiko Nosho, Takako Kawasaki, Janina A. Longtine, Charles S. Fuchs, Mutsuko Ohnishi, Yuko Suemoto, Gregory J. Kirkner, Dimity Zepf, Liying Yan, Shuji Ogino, PIK3CA Mutation in Colorectal Cancer: Relationship with Genetic and Epigenetic Alterations Neoplasia. ,vol. 10, pp. 534- 541 ,(2008) , 10.1593/NEO.08336
Maela Del Grammastro, Mariagrazia Sciarrotta, Sara Malatesta, Carmen Nuzzo, Giovanna Finocchiaro, Bruno Perrucci, Donatella Carlone, Alain J. Gelibter, Anna Ceribelli, Andrea Mezzetti, Stefano Iacobelli, Francesco Cognetti, Fiamma Buttitta, Antonio Marchetti, Michele Milella, Lara Felicioni, Federico Cappuzzo, Luciana Irtelli, Clinical Implications of KRAS Mutations in Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors: An Important Role for Mutations in Minor Clones Neoplasia. ,vol. 11, pp. 1084- 1092 ,(2009) , 10.1593/NEO.09814
Laura C. Lovato, Dennis J. Ahnen, Paul A. Bunn, Frank L. Meyskens, Polly Feigl, John D. Wells, Grant Stemmerman, Gang Quan, Cecelia Fenoglio-Preiser, John S. Macdonald, Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Research. ,vol. 58, pp. 1149- 1158 ,(1998)
Gabriel Capellà, Lourdes Farré, Isolda Casanova, Adela Mazo, Sílvia Guerrero, Ramon Mangues, K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression. Cancer Research. ,vol. 60, pp. 6750- 6756 ,(2000)
Jingfang Ju, Masakazu Yamamoto, Kenji Kudo, Kazuhiko Hayashi, Yaguang Xi, Go Nakajima, Kazumi Uchida, Ken Takasaki, Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. Cancer Genomics & Proteomics. ,vol. 3, pp. 317- 324 ,(2006)
S. Kopetz, J. Desai, E. Chan, J. R. Hecht, P. J. O'Dwyer, R. J. Lee, K. B. Nolop, L. Saltz, PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors. Journal of Clinical Oncology. ,vol. 28, pp. 3534- 3534 ,(2010) , 10.1200/JCO.2010.28.15_SUPPL.3534
Yohko Hikiba, Tsuneo Ikenoue, Hideaki Ijichi, Jun Aragaki, Keisuke Tateishi, Fumihiko Kanai, Takao Kawabe, Takaaki Imamura, Jun Imamura, Takayuki Kawakami, Miki Ohta, Yasuo Tanaka, Masayuki Matsumura, Masao Omata, Functional analysis of mutations within the kinase activation segment of B-Raf in human colorectal tumors. Cancer Research. ,vol. 63, pp. 8132- 8137 ,(2003)